Literature DB >> 9988155

Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.

M A Bwaka1, M J Bonnet, P Calain, R Colebunders, A De Roo, Y Guimard, K R Katwiki, K Kibadi, M A Kipasa, K J Kuvula, B B Mapanda, M Massamba, K D Mupapa, J J Muyembe-Tamfum, E Ndaberey, C J Peters, P E Rollin, E Van den Enden, E Van den Enden.   

Abstract

During the 1995 outbreak of Ebola hemorrhagic fever in the Democratic Republic of the Congo, a series of 103 cases (one-third of the total number of cases) had clinical symptoms and signs accurately recorded by medical workers, mainly in the setting of the urban hospital in Kikwit. Clinical diagnosis was confirmed retrospectively in cases for which serum samples were available (n = 63, 61% of the cases). The disease began unspecifically with fever, asthenia, diarrhea, headaches, myalgia, arthralgia, vomiting, and abdominal pain. Early inconsistent signs and symptoms included conjunctival injection, sore throat, and rash. Overall, bleeding signs were observed in <45% of the cases. Typically, terminally ill patients presented with obtundation, anuria, shock, tachypnea, and normothermia. Late manifestations, most frequently arthralgia and ocular diseases, occurred in convalescent patients. This series is the most extensive number of cases of Ebola hemorrhagic fever observed during an outbreak.

Entities:  

Mesh:

Year:  1999        PMID: 9988155     DOI: 10.1086/514308

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  135 in total

1.  Ebola erupts again.

Authors:  E Weir
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

Review 2.  Emerging viral diseases.

Authors:  S T Nichol; J Arikawa; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 3.  Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.

Authors:  Masayuki Saijo; Masahiro Niikura; Tetsuro Ikegami; Ichiro Kurane; Takeshi Kurata; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2006-04

4.  Understanding the dynamics of Ebola epidemics.

Authors:  J Legrand; R F Grais; P Y Boelle; A J Valleron; A Flahault
Journal:  Epidemiol Infect       Date:  2006-09-26       Impact factor: 2.451

Review 5.  Nosocomial spread of viral disease.

Authors:  C Aitken; D J Jeffries
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

6.  Assessing the international spreading risk associated with the 2014 west african ebola outbreak.

Authors:  Marcelo F C Gomes; Ana Pastore Y Piontti; Luca Rossi; Dennis Chao; Ira Longini; M Elizabeth Halloran; Alessandro Vespignani
Journal:  PLoS Curr       Date:  2014-09-02

7.  Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Authors:  Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

8.  Quantifying the epidemic spread of Ebola virus (EBOV) in Sierra Leone using phylodynamics.

Authors:  Samuel Alizon; Sébastien Lion; Carmen Lía Murall; Jessica L Abbate
Journal:  Virulence       Date:  2014       Impact factor: 5.882

9.  Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes.

Authors:  Andrea Rivera; Ilhem Messaoudi
Journal:  ACS Infect Dis       Date:  2015-03-30       Impact factor: 5.084

10.  Protection against lethal challenge by Ebola virus-like particles produced in insect cells.

Authors:  Yuliang Sun; Ricardo Carrion; Ling Ye; Zhiyuan Wen; Young-Tae Ro; Kathleen Brasky; Anysha E Ticer; E Ellen Schwegler; Jean L Patterson; Richard W Compans; Chinglai Yang
Journal:  Virology       Date:  2008-11-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.